← All Vaxxinity, INC filings

Vaxxinity, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
VAXX
Vaxxinity, INC
8-K: Vaxxinity to Voluntarily Delist from Nasdaq and Deregister its Common Stock
Vaxxinity, Inc. has announced its intention to voluntarily delist from the Nasdaq Global Market and deregister its Class A common stock, citing low trading value and high costs associated with being a public company.
OTC.Pink
VAXX
Vaxxinity, INC
8-K: Vaxxinity Approves Option Repricing to Retain and Motivate Employees
Vaxxinity's Board of Directors approved a repricing of underwater stock options for employees and executives, reducing the exercise price to $0.70 per share.
OTC.Pink
VAXX
Vaxxinity, INC
8-K: Vaxxinity Receives Nasdaq Delisting Notice Due to Minimum Bid Price Deficiency
Vaxxinity, Inc. has received a notice from Nasdaq for not meeting the minimum bid price requirement of $1.00 per share, and has until August 7, 2024, to regain compliance.